AC
MRNS

Antara Capital’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Antara Capital’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,698,794
Closed -$6.76M – 138
2022
Q4 		$6.76M Buy
1,698,794
+702,000
+70% +$3.45M 0.19% 84
2022
Q3 		$6.63M Buy
996,794
+529,313
+113% +$3.26M 0.18% 84
2022
Q2 		$2.26M Buy
467,481
+277,273
+146% +$1.69M 0.1% 131
2022
Q1 		$1.78M Buy
+190,208
New +$1.89M 0.05% 149

Other funds holding MRNS

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Antara Capital's MRNS Position: Q1 2023 in Review

Antara Capital sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2023, closing a stake of 1,698,794 shares — an estimated $6.76M sold.

Antara Capital first reported a position in MRNS in Q1 2022 and held it in 4 quarters. The position peaked at $6.76M in Q4 2022. 86 funds tracked by Wall St. Rank hold MRNS as of Q1 2023.

  • Antara Capital reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2023 after selling out during the quarter.
  • Antara Capital sold 1,698,794 Marinus Pharmaceuticals, Inc shares in Q1 2023, an estimated $6.76M.
  • Antara Capital first reported a position in Marinus Pharmaceuticals, Inc in Q1 2022 and held it in 4 quarters.
  • Antara Capital's Marinus Pharmaceuticals, Inc position peaked at $6.76M in Q4 2022.
  • 86 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2023.

Based on Antara Capital's 13F filing for Q1 2023, filed 12 May 2023.